video library

Facility Spotlight: Winnipeg, Manitoba, Canada

For more than 30 years, our Winnipeg, Manitoba (Canada) site has offered a broad range of expertise for drug substance and drug product manufacturing. The 150,000-sq.ft. facility manufactures polyclonal hyperimmune products, plasma therapeutics, lipoproteins, and mRNA products, and houses a SA25 aseptic filling workcell — a gloveless, robotic isolator ideal for high-value biologic products.

HubSpot Video


Learn more about how our Winnipeg site is equipped to support your next clinical or commercial drug candidate.

Rockville, MD

An Inside Look at Drug Product Manufacturing

Emergent's drug product manufacturing facility in Rockville, MD is home to the groninger® INTEGRA, a state-of-the-art high speed...

READ MORE

Focus on Fill and Finish

Kelly Christiansen, vice president & general manager of Emergent CDMO's Rockville drug product manufacturing facility recently...

READ MORE

The Demand for Nanoparticles in Drug Formulation is Rising

Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect...

READ MORE